• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STIMWAVE TECHNOLOGIES INC. STIMQ PERIPHERAL NERVE STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STIMWAVE TECHNOLOGIES INC. STIMQ PERIPHERAL NERVE STIMULATOR Back to Search Results
Model Number STQ4-RCV-A0, STQ4-SPR-B0
Device Problems Break (1069); Migration (4003)
Patient Problem Erosion (1750)
Event Type  Injury  
Manufacturer Narrative
The implanting clinician attempted to revise the proximal end of the stimulator and also removed a granuloma that was near the area where the stimulator fractured.In the midst of this operation the receiver came out of the stimulator, indicating to the implanting clinician that the stimulators had fractured and migrated, causing loss of therapy.On (b)(6) 2020, the patient had a revision in which both stimulators were removed and two new stimulators were implanted.The revision was completed without complication and the patient has reported receiving therapy.On (b)(6) 2020, the cr stated that the implanting clinician believes that the stimulator fracture resulting in migration is due to a granuloma forming around the stimulator and causing tension.The patient was reported to be doing well and no further issues were noted.Through a review of sterilization and packaging records for the respective product lots, stimwave has confirmed that the product was delivered sterile, no trend of infection is evident for lot #'s swo190414 and swo190424, validated sterilization parameters were used, and sterile barriers were verified to be intact following packaging.Sterility of the stimwave device did not contribute to granuloma formation.The root cause of this complaint is due to a granuloma forming around the stimulators, causing them to fracture and migrate leading to a loss of therapy.
 
Event Description
On (b)(6) 2020, the patient met with the implanting clinician reporting loss of therapy.The clinician observed via x-ray that both stimulators had fractured.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STIMQ PERIPHERAL NERVE STIMULATOR
Type of Device
PERIPHERAL NERVE STIMULATOR
Manufacturer (Section D)
STIMWAVE TECHNOLOGIES INC.
1310 park central boulevard s.
pompano beach,
Manufacturer (Section G)
STIMWAVE TECHNOLOGIES INC.
1310 park central boulevard s.
pompano beach,
Manufacturer Contact
luis fontaneda
1310 park central boulevard s.
pompano beach, 
MDR Report Key10084230
MDR Text Key199090747
Report Number3010676138-2020-00047
Device Sequence Number1
Product Code GZF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K171366
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 04/27/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/22/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date04/01/2021
Device Model NumberSTQ4-RCV-A0, STQ4-SPR-B0
Device Lot NumberSWO190414, SWO190424
Was Device Available for Evaluation? No
Date Manufacturer Received04/26/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/26/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-